Polyscope specializes in the development and production of styrene maleic anhydride copolymers used in the electronics, automotive, and specialty coatings and inks markets.

January 31, 2022

1 Min Read
M&A on touchscreen
Image: Alamy/Thodonal

Specialty materials manufacturer Vertellus announced today the acquisition of Polyscope Polymers B.V., a supplier of specialty additives for coatings, electronics applications, and engineering polymers based in Geleen, Netherlands. The addition of Polyscope’s complementary product portfolio and advanced manufacturing capabilities expands Vertellus’ European production capabilities and extends its reach in high-growth end markets, said the news release.

Headquartered in Indianapolis, Vertellus was founded in 1857 and has more than 1,300 employees across 15 international research and manufacturing facilities. 

Polyscope is described as a global leader in the development and production of styrene maleic anhydride (SMA) copolymers necessary for a range of product applications. It operates a state-of-the-art production facility in Geleen and serves as a key partner to more than 300 customers in over 35 countries. 

“Polyscope adds a complementary portfolio of high-quality solutions, a track record of innovation, and a world-class global platform in attractive end markets,” said Vertellus CEO John Van Hulle. “Together we will serve our customers with a unique product offering and our shared value-driven approach.” 

From Polyscope’s perspective, Vertellus is well-positioned to support the company’s next phase of growth and innovation, according to CEO Patrick Muezers. “We will be able to leverage Vertellus’ global resources, capabilities, and strong market leadership to better serve our customers and bring our high-quality products to additional customers throughout our markets.” 

Vertellus’ specialty ingredients and materials are found in personal care products, pharmaceuticals, medical devices, nutraceuticals, food & beverages, performance coatings, transportation additives, and more. The company is owned by Pritzker Private Capital and management.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like